How to buy Opiant Pharmaceuticals stock

Opiant Pharmaceuticals is a biotechnology business based in the US. Opiant Pharmaceuticals shares (OPNT) are listed on the NASDAQ and all prices are listed in US Dollars. Opiant Pharmaceuticals employs 37 staff and has a trailing 12-month revenue of around $22.3 million.

Opiant Pharmaceuticals stock price (NASDAQ: OPNT)

Use our graph to track the performance of OPNT stocks over time.

Opiant Pharmaceuticals shares at a glance

• Key figures

Information last updated 2023-03-23.

Latest market close	$20.65
52-week range	$7.34 - $24.50
50-day moving average more info button	$20.50
200-day moving average more info button	$14.79
Wall St. target price	$21.00
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-6.53

Buy Opiant Pharmaceuticals stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Opiant Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Opiant Pharmaceuticals price performance over time

Historical closes compared with the close of $20.65 from 2023-03-02

1 week (2023-03-18)	N/A
1 month (2023-03-01)	20.65
3 months (2022-12-29)	1.77%
6 months (2022-09-29)	97.23%

1 year (2022-03-25)	N/A
2 years (2021-03-29)	99.32%
3 years (2020-03-27)	124.95%
5 years (2018-03-28)	8.40%

Opiant Pharmaceuticals financials

Revenue TTM	$22.3 million
Gross profit TTM	$21.9 million
Return on assets TTM	-35.51%
Return on equity TTM	-105.87%
Profit margin	-148.13%
Book value	$3.97
Market capitalisation more info button	$108.8 million

TTM: trailing 12 months

Opiant Pharmaceuticals share dividends

We're not expecting Opiant Pharmaceuticals to pay a dividend over the next 12 months.

Have Opiant Pharmaceuticals's shares ever split?

Opiant Pharmaceuticals's shares were split on a 1:100 basis on 30 December 2014. So if you had owned 100 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Opiant Pharmaceuticals shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for Opiant Pharmaceuticals shares which in turn could have impacted Opiant Pharmaceuticals's share price.

Opiant Pharmaceuticals share price volatility

Over the last 12 months, Opiant Pharmaceuticals's shares have ranged in value from as little as $7.34 up to $24.5. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Opiant Pharmaceuticals's is 0.8316. This would suggest that Opiant Pharmaceuticals's shares are less volatile than average (for this exchange).

Opiant Pharmaceuticals overview

Opiant Pharmaceuticals, Inc. , a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016.

Frequently asked questions

What percentage of Opiant Pharmaceuticals is owned by insiders or institutions?
Currently 7.635% of Opiant Pharmaceuticals shares are held by insiders and 41.998% by institutions. How many people work for Opiant Pharmaceuticals?
Latest data suggests 37 work at Opiant Pharmaceuticals. When does the fiscal year end for Opiant Pharmaceuticals?
Opiant Pharmaceuticals's fiscal year ends in July. Where is Opiant Pharmaceuticals based?
Opiant Pharmaceuticals's address is: 233 Wilshirre Boulevard, Santa Monica, CA, United States, 90401 What is Opiant Pharmaceuticals's ISIN number?
Opiant Pharmaceuticals's international securities identification number is: US6837501039 What is Opiant Pharmaceuticals's CUSIP number?
Opiant Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 53224T105